Effects of a Buriti Suplpement on Body Composition and Function in Older Adults
Effects of "Nutricer®" Vegan Protein Supplementation Based on Buriti (Mauritia Flexuosa), Rice, and Pea on Body Composition, Flexibility, Balance, and Dietary Frequency in Elderly Tai Chi Chuan Practitioners: A Placebo-Controlled Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Aging is a natural process commonly associated with loss of muscle mass, reduced flexibility, and impaired balance, directly affecting the quality of life of older adults. Tai Chi Chuan, a traditional mind-body practice, has been shown to improve balance, flexibility, and overall well-being in elderly populations. In addition, nutritional supplementation may enhance these effects, particularly when based on plant-derived functional compounds.This study aims to evaluate the effects of vegan protein supplementation with Nutricer®-based on buriti (Mauritia flexuosa), rice, and pea-on body composition, muscle strength, flexibility, balance, and dietary frequency in elderly women practicing Tai Chi Chuan. This is a placebo-controlled clinical trial involving 40 elderly female participants, randomly assigned into two groups: an experimental group (n = 20), receiving Nutricer® supplementation, and a control group (n = 20), receiving a placebo (maltodextrin), both alongside regular Tai Chi Chuan practice.Buriti is known for its antioxidant and anti-inflammatory properties, which may contribute to the preservation of muscle and functional health. It is expected that the combination of vegan protein supplementation and Tai Chi Chuan practice will result in significant improvements in functional health, providing a natural, accessible, and safe strategy for healthy aging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 16, 2026
CompletedFirst Posted
Study publicly available on registry
July 21, 2026
CompletedJuly 23, 2026
July 1, 2026
5 months
July 16, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Body weight (kg)
Body weight will be measured using a calibrated digital scale and recorded in kilograms (kg).
Baseline and week 12.
Lean body mass percentage (%)
Lean body mass percentage will be assessed using bioelectrical impedance analysis (BIA) and expressed as a percentage of total body mass.
Baseline and week 12
Body fat percentage (%)
Body fat percentage will be assessed using bioelectrical impedance analysis (BIA) and expressed as a percentage of total body mass.
Baseline and week 12.
Handgrip strength (kg)
Assessment of muscle strength using handgrip strength test with a digital dynamometer and recorded in kilograms (kg).
Baseline and week 12
Plasma glucose concentration (mg/dL)
Plasma glucose concentration (mg/dL) will be measured using an enzymatic colorimetric assay.
Baseline and Week 12
Percentage of plasma glycosylated hemoglobin (HbA1c) (%)
Glycosylated hemoglobin (HbA1c) (%) will be measured in whole blood.
Baseline and Week 12
Plasma LDL cholesterol concentration (mg/dL)
Plasma low-density lipoprotein (LDL) cholesterol concentration (mg/dL) will be measured using an enzymatic colorimetric assay.
Baseline and week 12
Plasma HDL cholesterol concentration (mg/dL)
Plasma high-density lipoprotein (HDL) cholesterol concentration (mg/dL) will be measured using an enzymatic colorimetric assay.
Baseline and week 12
Plasma total cholesterol concentration (mg/dL)
Plasma total cholesterol concentration (mg/dL) will be measured using an enzymatic colorimetric assay.
Baseline and Week 12
Secondary Outcomes (2)
Functional balance assessed by the Timed Up and Go (TUG) test
Baseline and week 12
Flexibility assessed by the Sit-and-Reach test
Baseline and week 12
Study Arms (2)
Experimental Group
EXPERIMENTALParticipants will receive vegan protein supplementation with Nutricer® (based on buriti, rice, and pea), in addition to regular Tai Chi Chuan practice.
Placebo Comparator
PLACEBO COMPARATORParticipants will receive a placebo (maltodextrin), in addition to regular Tai Chi Chuan practice
Interventions
Vegan protein supplement based on buriti (Mauritia flexuosa), rice and pea.
Placebo supplement (maltodextrin), administered daily during the study period.
Participants will participate in a supervised Tai Chi Chuan program consisting of structured sessions led by a qualified instructor throughout the intervention period.
Eligibility Criteria
You may qualify if:
- Female participants aged 60 years or older
- Participation in a Tai Chi Chuan program (at least twice per week, 60-minute sessions)
- Commitment to remain in the study throughout the intervention period (e.g., 12 weeks)
- Ability to understand and respond to questionnaires and perform the proposed physical tests
- Willingness to participate and provide written informed consent (Informed Consent Form)
You may not qualify if:
- Current use of protein supplements, vitamins, or similar products to the study supplement
- Medical contraindications to performing light to moderate physical exercise
- Diseases or conditions that significantly impair mobility (e.g., severe stroke sequelae, advanced Parkinson's disease)
- Moderate to severe cognitive impairment (e.g., dementia)
- Irregular participation in Tai Chi Chuan sessions (absence greater than 20% during the intervention period)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
State University of Minas Gerais
Montes Claros, Minas Gerais, 39401002, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sérgio H Santos, PhD
Federal University of Minas Gerais
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 16, 2026
First Posted
July 21, 2026
Study Start
August 1, 2025
Primary Completion
January 1, 2026
Study Completion
June 1, 2026
Last Updated
July 23, 2026
Record last verified: 2026-07